The multifunctional or moonlighting protein CD26/DPPIV
- 1 February 2003
- journal article
- review article
- Published by Elsevier in European Journal of Cell Biology
- Vol. 82 (2) , 53-73
- https://doi.org/10.1078/0171-9335-00302
Abstract
No abstract availableKeywords
This publication has 220 references indexed in Scilit:
- GPI-microdomains: a role in signalling via immunoreceptorsImmunology Today, 1999
- Decreased Dipeptidyl Peptidase IV Enzyme Activity of Plasma Soluble CD26 and Its Inverse Correlation with HIV-1 RNA in HIV-1 Infected IndividualsClinical Immunology, 1999
- Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1αFEBS Letters, 1998
- Suppression of arthritis by the inhibitors of dipeptidyl peptidase IVInternational Journal of Immunopharmacology, 1997
- Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) geneImmunogenetics, 1994
- Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequencesFEBS Letters, 1993
- Structural relationship between lipases and peptidases of the prolyl oligopeptidase familyFEBS Letters, 1992
- Surface membrane CD4 turnover in phorbol ester stimulated T‐lymphocytesFEBS Letters, 1990
- Increased activity of dipeptidyl peptidase IV in serum of hepatoma-bearing rats coincides with the loss of the enzyme from the hepatoma plasma membraneCellular and Molecular Life Sciences, 1986
- On the active site of proteases. III. Mapping the active site of papain; specific peptide inhibitors of papainBiochemical and Biophysical Research Communications, 1968